BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 688166 for the last quarter is 338.56 M CNY, and it's 28.56% higher compared to the previous quarter. The net income of Q1 24 is 64.07 M CNY.